MD

Mohamed Dilkhas Kolo Parambil

Active Director Managing Director DIN 11227207
DIN 11227207 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohamed Dilkhas Kolo Parambil

Data last updated:

Mohamed Dilkhas Kolo Parambil is a Managing Director at Mednova Study Abroad Private Limited (since 2025).

DIN 11227207
Primary Designation Managing Director
First Appointment 04 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mednova Study Abroad Private Limited U85499KL2025PTC096067
Managing Director04 Aug 20252025Active

Board colleagues of Mohamed Dilkhas Kolo Parambil

NameDINCompanyDesignation
Khalid11227206Mednova Study Abroad Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mednova Study Abroad Private Limited
Premium access

Shareholding and investment profile for Mohamed Dilkhas Kolo Parambil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohamed Dilkhas Kolo Parambil

Mohamed Dilkhas Kolo Parambil currently holds 1 directorship: Mednova Study Abroad Private Limited (Managing Director, since 04 Aug 2025).

Mohamed Dilkhas Kolo Parambil was first appointed on 04 Aug 2025 as Managing Director at Mednova Study Abroad Private Limited.

The current boards of Mohamed Dilkhas Kolo Parambil's companies include Khalid (Mednova Study Abroad Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available